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Type 2 diabetes (T2D) is a disease that is characterized by raised levels of glucose in the blood combined
with insulin resistance and relative insulin deﬁciency. The pathogenesis of type 2 diabetes is associated
with the induction of the unfolded protein response (UPR). While UPR aims to restore tissue homeostasis
following stress of the endoplasmic reticulum (ER), prolonged ER stress triggers apoptosis at least in part
through the unfolded protein response (UPR)-activated transcription factor C/EBP (CCAAT/enhancer
binding protein) homologous protein (CHOP). CHOP has elevated as a critical mediator connecting
accumulation and aggregation of unfolded proteins in the ER and oxidative stress and also contributes to
the induction of apoptosis in b-cell (beta-cell) e cells under conditions of increased insulin demand. p21
is a cell cycle regulator that is implicated in the regulation of the UPR by various mechanisms involving
inhibition of apoptosis and facilitation of the regeneration capacity of the b cells. In this review we
summarize the role of ER stress in the pathogenesis of type 2 diabetes which is associated with the
induction of the unfolded protein response (UPR). We also review recent evidence associating p21 ac-
tivity with b cell health and regenerative capacity by mechanisms that may interfere with the effects of
p21 in the UPR or operate independently of ER stress. Most likely understanding the molecular details of
the pathogenesis of type 2 diabetes will be beneﬁcial for the management of the disease.
 2013 Elsevier Masson SAS. All rights reserved.1. Introduction
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son SAS. All rights reserved.failure of the body to secrete insulin at adequate levels or the cells
ignore insulin [1]. Recent studies suggest that p21 represses b celle
duplication rate and facilitates the recovery of mice from hyper-
glycemia caused by streptozotocin-induced diabetes [2]. Interfer-
ence with the induction of apoptosis during diabetes, such as by
genetic deletion of CHOP, rescues b cells from ER stress e related
apoptosis [3]. A fundamental question regarding the decision for b-
cell survival versus apoptosis is which UPR sub-pathways play a
role in this transition and how the latter is being regulated. To that
end it is of particular importance to understand which the key
sensors of these responses are and how these responses are inte-
grated into the cellular machinery to become protective or disad-
vantageous to b-cell survival upon short-term or long-term ER
stress.2. Interplay between endoplasmic reticulum e homeostasis
and protein quality control
The endoplasmic reticulum (ER) is a highly dynamic multifold
membranous structure that is responsible for post-translational
folding, modiﬁcation and trafﬁcking of proteins to the cell surface
or to the Golgi compartment, intracellular calcium homeostasis and
lipid biosynthesis. The ER responds to genetic and environmental
C. Mihailidou et al. / Biochimie 99 (2014) 19e2720stress response and provides a catalyst proper folding environment
for more or less one third of all proteins. All eukaryotic cells have
evolved speciﬁc mechanisms to preserve ER functions under con-
ditions of stress [4]. Growing evidence shows that endoplasmic
reticulum (ER) stress is an important mechanism linking obesity,
insulin resistance and glucose intolerance [5].
Homeostatic adaptation to endoplasmic reticulum is extremely
important in insulin-secreting beta-cells because when homeo-
stasis is disrupted, misfolded or unfolded proteins may accumulate
in the ER, a condition referred to as ER stress [6]. Numerous per-
turbations in the normal functions of the ER such as hypoxia, al-
terations in calcium, nutrient availability, mutations in the ER-
chaperones, inhibition of protein glycosylation, reduced disulﬁde
bond formation and viral infections, may initiate an evolutionarily
conserved cellular response that is designated as the unfolded
protein response (UPR). This biochemical response initially aims to
restore cellular homeostasis but can eventually promote cell death
if ER dysfunction is acute or prolonged [7].
The UPR is comprised of three distinct biochemical branches
linked to three intracellular receptors that upon activation initiate
speciﬁc biochemical events: (1) Activated PERK (endoplasmic re-
ticulum kinase) that causes translational attenuation by phos-
phorylating, eIF2 (eukaryotic Initiation Factor-2). However, some
speciﬁc mRNAs, including ATF4 (Activating transcription factor 4),
are translated under these conditions. ATF4 can function as an
activator of genes encoding adaptive functions as well as the
glucose-regulated proteins [7]; (2) IRE1a (Inositol-requiring
enzyme-1a) that induces the alternative splicing, and thus the
activation of the transcription factor XBP1 (X-box binding protein
1) mRNA and produces XBP1-spliced (XBP1s). The activated form
of XBP1 upregulates many ER chaperones and genes involved in
ERAD (Endoplasmic-reticulum-associated protein degradation),
various UPR ‘stress genes’, as well as enzymes involved in mem-
brane biogenesis [7]; (3) ATF6 (activating transcription factor 6)
that translocates to the Golgi, where it is subsequently cleaved
rendering the activated form of the protein. ATF6 induces genes
involved in ER homeostasis and membrane biogenesis [8].
There is an array of four types of speciﬁc cellular responses that
are induced during the earlier phases of the UPR and aim to over-
come stress:
1. Translational attenuation that occurs in order to overcome the
load of ER and is triggered by the PERK-dependent phosphory-
lation of eIF2.
2. Induction of UPR-related genes, primarily chaperones such as
Bip (Binding immunoglobulin protein)/GRP78 (78 kDa glucose-
regulated protein) and GRP74 (74 kDa glucose-regulated pro-
tein) in order to prevent further accumulation of unfolded/
misfolded proteins.
3. Enzymes including protein disulﬁde isomerase (PDI) and
SERCA2 (sarcoplasmic ER Caþ2 eATPase2) that increase the ca-
pacity of endoplasmic reticulum for protein folding. In addition,
during UPR the transcriptional induction of genes involved in
the biosynthesis of amino acids occurs, as well as the tran-
scription of genes implicated in glutathione biosynthesis that
protects against oxidative stress.
4. Stimulation of NFkB (nuclear factor kappa-light-chain-enhancer
of activated B cells) activity that is a transcription factor acting as
a mediator of immune and anti-apoptotic response [9].
If these responses are not sufﬁcient for the re-establishment of
the cellular homeostasis, ERAD (ER-associated protein degradation)
components are induced in order to eliminate the misfolded pro-
teins [9]. Finally, if cellular damage is deemed irreversible and the
pro-survival activity of the UPR is not sufﬁcient for the retention ofcellular homeostasis, apoptosis is induced by stimulation of the
CCAAT/enhancer-binding homologous protein (CHOP) and activa-
tion of the JNK (c-Jun N-terminal kinase) kinase and caspase-12 [9].
3. CHOP-dependent regulation of p21. Possible switching
mechanism from the pro-survival to the pro-apoptotic
response of UPR
Obviously, there is a nonstop interplay between survival and
death decisions during ER stress that determine the transition
from the prosurvival towards the proapoptotic state of UPR
[10,11]. We have provided evidence that CHOP regulates the
expression of the cell cycle regulator p21 during ER stress. Phar-
macological induction of ER stress by tunicamycin suppresses p21
levels, an effect that coincides with the over-expression of CHOP.
CHOP suppresses p21 and initiates a pro-apoptotic program. Our
ﬁndings indicate that CHOP relieves the anti-apoptotic activity of
p21 during ER stress [12].
4. ER stress-related mechanism of glucose-induced beta cell
dysfunction
Prolonged in vitro exposure of beta cell lines or islets to glucose
increases ER stress markers in the majority of studies. This is
related to the fact that increased glucose levels over-stimulate
insulin production that exhausts the insulin producing and
secreting activity of the b cells leading to ER stress. The homeo-
static consequences of the resulting UPR become apparent by the
observation that overproduction of the ER chaperone 78 kDa
glucose-regulated protein (GRP78) partially prevents glucose-
induced beta cell dysfunction in vitro in INS-1 cells (a rat cell
line that secretes insulin in response to glucose concentrations in
the physiological range) [13].
5. Evidence for a crosstalk between the generation of ROS
and ER stress response
Several experimental results suggest that the production of
reactive oxygen species (ROS) results in misfolded protein-medi-
ated cell death. Oxidative protein folding takes place in the ER
implicating various oxidoreductases, including protein disulphide
isomerase (PDI), PDIR, PDIp, P5 ERp57 and ERp72. In vitro forma-
tion, isomerization and reduction of disulphide bonds are catalyzed
by PDI. During disulphide bond formation, cysteine residues within
the PDI active site accept two electrons from the substrate resulting
in the oxidation of this protein, the reduction of the PDI active site
and ﬁnally in the production of hydrogen peroxide. Thus, reactive
oxygen species (ROS) are produced in a cell during the synthesis of
the disulphide bonds in the ER which may elicit DNA and protein
damage [14]. Furthermore, glutathione is involved in the reduction
of mispaired disulﬁde bonds that may destroy the cellular gluta-
thione pool which is crucial for the neutralization of the reactive
oxygen species (ROS) and the blockade of the oxidation of the
cytosolic proteins. Considering that oxidative protein folding occurs
in the ER and also that disturbances in protein folding can have
damaging consequences in the cells, alterations in the redox status
or the generation of ROS could directly or indirectly (or both) affect
ER homeostasis and protein folding and eventually cellular func-
tion. Consequently, cells with a powerful biosynthetic load, deﬁ-
cient UPR, or defective ER-associated protein degradation (ERAD)
are more sensitive to oxidative stress [15].
Considering that insulin biosynthesis involves disulphide bond
formation oxidative stress plays a causal role in glucose-induced
beta cell dysfunction both in vivo and in vitro. Analysis of clinical
specimens indicates that both, ER stress and oxidative stress are
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recent studies demonstrate a close interrelationship between
oxidative stress and ER-stress in beta cells [15].
6. Contribution of ER stress in the development of metabolic
actions in insulin target tissues
A characteristic feature of T2D is the insulin resistance (IR),
which occurs when cells are unable to respond to the normal
behavior actions of the hormone insulin, forcing the beta cells of
the pancreas to synthesize more insulin in order to address the
needs for energy of the body and to maintain glucose homeostasis.
This cellular stress progressively induces apoptosis of pancreatic
beta cells. IR is displayed in themain target tissues of insulin, which
is adipose tissue, liver and muscles. The ER stress response has
strongly been implicated in the pathogenesis of diabetes [16]. ER
stress affects insulin action in liver, skeletal muscles and adipose
tissue as well as the function and mass of the pancreatic beta cells
[17].
6.1. Role of ER stress in adipose tissue IR
Adipose tissue responds to metabolic and endocrine functions.
Adipose tissues produce leptin and adiponectin to regulate food
intake and secrete pro- and anti-inﬂammatory adipokines to adjust
inﬂammatory responses and insulin resistance. Adipocytes provide
fatty acids for use as an energy source in adipose tissue. Inﬂam-
matory responses in adipose tissue increase the levels of various
pro-inﬂammatory cytokines, including the tumor necrosis factor-a
(TNF-a), interleukin-6 (IL-6), IL-1b, and CC-chemokine ligand 2
(CCL2). These proinﬂammatory cytokines cause oxidation and
endoplasmic reticulum (ER) stress, which can also provoke insulin
resistance in peripheral tissues. A direct link between ER-stress and
insulin signaling in adipose cells has been revealed by several
studies [18].
ER stress decreases the secretion of the adipokines and conse-
quently reduces insulin signaling and functionality in 3T3-L1 and
primary mouse adipocytes without inhibiting glucose transport
[19]. It has been recognized that endoplasmic reticulum dysfunc-
tion and chronic inﬂammation develops in adipose tissue on high
fat diet mice. ER-stress is generated by free fatty acid which stim-
ulates reactive oxygen species (ROS) and enhances pro-
inﬂammatory cytokine gene expression in 3T3-L1 adipocytes.
Recently it has been shown that ER stress reduces the expression of
the lipid protein, perilipin A and enhances lipolysis in adipose cells.
Inducers of ER-stress activate a lipolytic reaction. The consequences
of ER stress on adipose lipolysis were not reversed by inhibitors of
several stress-activated kinases such as JNK, p38MAPK and PKC
(Protein kinase C), kinases that are usually involved in the negative
regulation of insulin signaling [20]. These data support a role of ER-
stress and modulation of inﬂammatory responses and in lipid
homeostasis.
ER stress inducers enhance a decrease of both leptin and adi-
ponectin secretion and an increase of IL-6 secretion [18]. The
decrease of the expression of ER disulﬁde-bond A oxidoreductase-
like (Dsba-L) weakens adiponectin folding and multimerization,
leading to ER stress [21,22]. In addition, ER stress, through upre-
gulation of CHOP, reduces resistin (adipose tissue-speciﬁc secretory
factor transcription in adipocytes) [23].
Recent data showed that hyperhomocysteine (HHcy) induces
insulin resistance in adipose tissue which in turn promotes insulin
resistance. Variant ER stress inducers were increased in adipose
tissue of HHcy mice. HHcy activates c-Jun N-terminal kinase (JNK),
contributed in insulin resistance by inhibiting protein kinase B
(PKB) activation. Furthermore, JNK activated c-Jun and p65, whichstimulated the transcription of pro-inﬂammatory cytokines [24].
Collectively these results indicate that ER stress is an important
player in adipose tissue dysfunction and promotes IR.6.2. Role of ER stress in liver IR
The liver is the main site of the Novo lipogenesis, which allows
the synthesis of fatty acids from excess carbohydrates in the diet.
Liver cells are the main key players of lipogenesis and glucose
metabolism. Various data have suggested that endoplasmic retic-
ulum (ER) stress could involve in fatty acid synthesis and choles-
terol metabolism [17]. SREBP-1c (sterol regulatory element-binding
protein 1) which is an activator of lipogenic gene transcription is
activated by ER-stress. During prolonged ER stress GRP78 is
released from SREBP-1c by unmasking the Golgi localization signal
on SREBP-1c, which then migrates to the Golgi apparatus where
SREBP-1c is proteolytically processed to yield an active fragment
that enters to the nucleus and stimulates lipogenic genes. This
processing is activated by site 1 and site 2 proteases in the Golgi
[25]. Reduced VLDL (Very-low-density lipoprotein) secretion and
increased SREBP-1c activation in combination with reduced lipid
oxidation aggravate lipogenesis and initiate to a vicious circle
leading to steatosis [26]. In hepatocytes XBP1s targets mRNAs
implicated in fatty acid synthesis. Indeed, a recent study showed
that liver-speciﬁc XBP1-null mice failed to develop steatosis when
placed to a high carbohydrate diet [27]. Furthermore, induction of
ER stress/UPR activation tunicamycin showed a remarkable down-
regulation of key lipid metabolic enzymes including CEBPa. Inter-
estingly tunicamycin treatment in livers of mice deleted ATF6, IRE1,
p58IK showed lack of expression of genes involved in metabolism
correlated to livers fromwild-type mice. However over-expression
of CHOP under tunicamycin treatment preserves the metabolic
gene expression and decreased hepatic steatosis in mice on a high
fat diet. So CHOP plays a key role in sustaining metabolism gene
under prolonged ER-stress and acts as a possible mediator of pro-
apoptotic and pro-inﬂammatory properties [28].6.3. Role of ER stress in muscle IR
High levels of circulating fatty acids in muscle cause insulin
resistance in type 2 diabetes. Several studies have reported an
involvement with increased plasma FFA (free fatty acids) levels by
lipid infusion leads to insulin resistance whereas lowering chroni-
cally elevated plasma FFA levels improves insulin sensitivity in
rodents and humans [29]. Generation of lipids, such as diac-
ylglycerol (DAG), fatty acyl-CoA and ceramides modify insulin
response and consequently lead to defects in glucose metabolism
and insulin resistance [30]. Recent studies have suggested that
endoplasmic reticulum (ER) stress seems to be one of the major
mechanisms involved in free fatty acid-induced insulin resistance
[31]. Increased ceramide accumulation was reported in skeletal
muscle of insulin resistance rodents [32,33] and inmuscles of obese
insulin-resistant patients [34]. They seem to be the most potent
inhibitors of insulin signaling in muscle cells [35]. Saturated fatty
acids, such as the accumulation of palmitate in muscle cells, induce
ceramide biosynthesis at the level of the endoplasmic reticulum
(ER) [36]. Increased levels of ceramides inhibit the insulin signaling
pathway through the inactivation of protein kinase B (PKB) via
mechanisms involving both protein kinase C (PKC) and protein
phosphatase 2A (PP2A) [37]. Studies have reported the role of ER
stress to mediate palmitate-induced IR in muscle cells. These have
shown that direct exposure of human primary myotubes, C2C12
myotubes [36], or L6 myotubes [38] to palmitate is capable of
stimulate ER stress. Similar results were studied in vivo from rats
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muscle IR may be linked to ER stress activation.7. Pancreatic beta cells: relationship between survival
signaling and apoptosis signaling
Many genetic and environmental variations trigger apoptotic
pathways that eventually eliminate damaged cells. The decision for
a protective or destructive stress response to cells depends on the
nature and the extent of the stress as well as the subjected speciﬁc
cell type [39].
Beta-cells represent a specialized type of cells in the pancreas
that are localized in the islets of Langerhans constituting 65e80% of
the cells in the islets [40]. Pancreatic beta cells, are the only source
of insulin in the body and are either lost or become dysfunctional
during the progression of diabetes that leads to the increase in the
glucose levels in the blood. Targeting, and restoring the function of
beta cells constitutes a major therapeutic strategy for the treatment
of diabetes [40]. Another important type of endocrine cells in the
pancreas is the alpha cells (15e20%) which produce glucagon and
elevates the glucose levels in the blood [41]. Beta cell mass is
dynamically regulated and is maintained through a delicate bal-
ance of regeneration and apoptosis [42].
A signiﬁcant increase in beta cell number develops under con-
ditions that include obesity and insulin resistance in order to cope
with the elevated demands for insulin production. The increase in
beta cell mass can occur through an increase in the cell number by
neogenesis and proliferation (hyperplasia), or through an increase
in the cell size (hypertrophy). Pancreatic b-cell mass is regulated by
interference with at least four independent mechanisms that
contribute to the emergence and function of b cells that are
responsible to cope with conditions related to the increased de-
mand for insulin production. Those include the induction of b cell
replication, the increase in b cell size, the de novo production of b
cells (neogenesis) and ﬁnally the inhibition of b cell apoptosis [43].8. Wolfram syndrome and b cell dysfunction
Hereditary syndromes such as the Wolfram syndrome illustrate
the intrinsic link between ER stress and diabetes. Wolfram syn-
drome is a neurodegenerative disorder that is characterized by
diabetes mellitus caused by non-autoimmune loss of beta cells,
deafness and optic atrophy [44]. Wolfram syndrome is activated by
mutations in the Wfs1 gene [45,46]. Despite that WFS1 is not a
direct marker of the UPR, analysis of Wfs1-deﬁcient mice demon-
strates that WFS1 function is linked with the preservation of ER
homeostasis. WFS1 is induced by XBP1 through a response
element-like motif in SH-SY5Y cells. In mice the pancreatic b cells
are subjected to ER-stress as shown by the phosphorylation of eIF2
and the production of the spliced form of XBP1. Mutations in Wfs1
repress intracellular calcium signaling, beyond glucose stimulation
associated with insufﬁcient insulin secretion and activate UPR-
regulated genes, while ultimately inhibits cell cycle and stimu-
lates apoptosis [44e47]. WFS1 interferes with the maturation of
plasma membrane proteins or the stability of ER membrane pro-
teins. The ﬁnding that WFS1 and Na(þ)/K(þ)ATPase b1 proteins
interact physically implies an important role for WFS1 in this
ATPase function. Decreased levels of this ATPase subunit were
identiﬁed in the fractions of plasmamembrane ofWfs1mutant cells
and of Wfs1 knockdown cells [48]. Accordingly loss of function in
the WFS1 induces ER stress-cell failure associated with diabetes.
Thus, WFS1 is involved inmembrane trafﬁcking, protein processing
and/or regulation of ER calcium homeostasis [48]. This discovery
suggested that WFS1 has a protective role against ER stress andreveals the consequences of the negative regulation of pancreatic
beta cell death in the pathogenesis of diabetes.
9. CDKs, regulators of the cell cycle
Cell-cycle progression is orchestrated by a series of events at
which cyclins and their partners, the cyclin-dependent kinases
(CDK) play a fundamental role. The activation of the kinase activity
of the CDKs is responsible for the sequential progression towards
the phases of the cell cycle. p21 is a member of the CIP/Kip family of
cyclin-dependent kinase inhibitors (CKIs). This family includes p27
and p57 [49]. These CKIs contain a region at the N terminal tran-
scriptional activation domain (NH2 terminus) that is crucial for the
inhibition of cyclin/Cdk complexes, while the COOH terminal re-
gions are changeable in length and function [50]. CKIs bind and
inhibit a wide range of cyclin/Cdk complexes, especially those
containing Cdk2 [51]. p21 expression up-regulates tumor-associ-
ated genes and proteins implicated in age-related diseases [52] and
stimulates viral promoters, including those of HIV (Human immu-
nodeﬁciency virus) and CMV (Cytomegalovirus) [53,54]. The
expression of p21 is regulated by p53 (tumor suppressor protein
53), through which p21 mediates the p53-dependent cell cycle
arrest in response to a variety of stress-inducing conditions. In
parallel with its cytostatic function as an inhibitor of cell cycle
progression p21 also operates as an inhibitor of apoptosis exhibit-
ing a pro-survival activity as it protects cells from p53-dependent
and p53-independent apoptosis [55]. This dual activity of p21 to
regulate both cell cycle and susceptibility to apoptosis appears to
play a regulatory role in the transition of UPR from its prosurvival
towards its proapoptotic mode of action [12].
The role of p21 in the regulation of other cellular activities
beyond the direct regulation of the cell cycle has recently attracted
increasing attention. Recent ﬁndings indicate that p21 is essential
for damage-induced paracrine antiapoptotic activity because of the
ability of p21 to imitate a transcriptional damage response without
DNA damage. p21 interacts with CDK8 that is a CDK family member
regulating several transcriptional programs involved in carcino-
genesis but has no role in cell cycle progression. Recent evidence
showed that pharmacological inhibition of CDK8 impeded different
chemotherapy-induced tumor-promoting paracrine functions of
normal and tumor cells, in vitro and in vivo [56].
10. Maintenance of glucose homeostasis in the p21-null
mouse
The ability of p21 to regulate both cell cycle and sensitivity
against apoptosis-inducing signals [57], in combination of various
lines of evidence pointing to a role of p21 in maintaining stem cell
function [58,59] prompted several investigators to explore a po-
tential association between p21 and diabetes.
The onset of oxidative stress during diabetes stimulated the
performance of studies assessing the role of p21 in the glucose-
related toxicity. Isolated rat pancreatic islet cells were treated with
H2O2 to provoke oxidative stress. Also in Zucker diabetic fatty rats
p21was overexpressed in islet cells using an adenovirus. Analysis of
gene expression in both experiments suggested that p21 mRNA
expression was elevated whereas insulin mRNA was diminished.
These ﬁndings support the notion that the expression of p21, which
can be induced by oxidative stress, aggravates in pancreatic islet
cells upon development of diabetes and suggest that by inhibiting
cell proliferation and insulin biosynthesis, the induction of p21 is
likely possible to be concerned in the beta cell glucose toxicity [60].
In vitro experiments showed that p21-deﬁcient mouse islets
treated with beta cell mitogens exhibited higher rates of DNA
synthesis as compared to p21-expressing islets which is in linewith
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in vivo studies conducted by the same research group in p21-
deﬁcient mice demonstrated that beta cell function and replica-
tion rate, as well as glucose homeostasis are not altered as
compared to the controls. This result suggests that either p21 does
not act alone to arrest the beta cell cycle or that its function is
complemented by another protein that can substitute for the loss of
p21 in b cells in vivo [61]. Interestingly though, in this study, p21
deﬁcient mice displayed lower insulin levels than controls implying
some dysfunction of the b cells which however did not become
clinically relevant, at least under the conditions used by the in-
vestigators in this study. It is conceivable though that p21 deﬁ-
ciency might have sensitized mice to the harmful consequences of
ER stress at levels below those that could interfere with glucose
homeostasis. This is in line with recent ﬁndings showing that p53-
deﬁcient cells and animals, that have reduced p21 levels, are more
sensitive to chronic and acute ER stress [62].
11. Over-expression of p21 in b-cells inhibits cell proliferation
Beta cell proliferation is a very important contributor to the
dynamic nature of adult beta cell mass [63]. p21 functions as an
inhibitor of the cell cycle progression, however, p21 ablation in
islets has no response on islet mass and glucose metabolism [64].
To determine whether p21 contributes to the b-cell failure associ-
ated with type 2 diabetes, the effects of p21 in the pancreatic b-cell
regeneration were examined by an alternative approach. Specif-
ically, the consequences of conditional p21 over-expression in b cell
proliferation were investigated by using a tetracycline-based
inducible system (Insulin-rtTA/TET-p21). In this system p21 is
controlled by the RIPII-rtTA promoter and therefore it was targeted
in the pancreatic b-cells. Therefore, following doxycycline (Dox)
administration the speciﬁc over-expression of p21 in islet b cells
was induced, which can inhibit the proliferation of b cells. Chronic
administration of doxycycline in these mice slowly elevated serum
glucose levels and eventually caused diabetes that apparently was
associated with the reduction in b-cell content and insulin pro-
duction [2].
11.1. Over-expression of p21 in mouse islets improves the recovery
from streptozotocin-induced diabetes
In the same study the recovery of the b-cells from streptozotocin
(STZ)-induced toxicity was also evaluated. STZ has the preferential
toxicity to pancreatic b cells and is known to induce insulin-
dependent diabetes, by eliciting damage in the beta cells of the
experimental animals [65]. Diabetes induction was accomplished
by utilizing a single high STZ dose, to reach toxicity to pancreatic b
cells. A single injection of a high dose of STZ, at 200 mg/kg, was
administered intra-peritoneal in mice on the eighth day of Dox
treatment and blood glucose levels were measured. Surprisingly,
the p21-overexpressing transgenic mice promoted the recovery
from STZ injury. Also p21-overexpressing mice were far more
capable to increase weight and attain normal glucose homeostasis
in the blood than control littermates. This demonstrates that when
b-cell self-duplication is repressed, such as when p21 is over-
expressed, islet damage from STZ treatment may re-activate alter-
native mechanisms to induce efﬁciently b-cell regeneration for
diabetic recovery [2].
11.2. Structural changes in islets in p21-overexpressing transgenic
mice
In order to determinewhich cells in the islets are responsible for
b cell regeneration morphometric analysis identiﬁed a networkoperated by the transcription factors Ngn3 (Pax4, Arx, Nkx2.2,
NeuroD1 and Pax6) and putative progenitor markers CD133 and c-
Met, to be expressed in the islets of transgenic mice that over-
express p21 following STZ treatment and stimulated islet injury.
Nonetheless, the expression of these genes was not detectable in
the islets of control mice directly after STZ injury. These results
highlight that the progenitor cell stimulation could be promoted
under conditionswhere b-cell self-renewal conditions are inhibited
[2], illustrating the role of p21 in b cell function.
11.3. p21-Overexpressing transgenic mice co-expressing endocrine
hormones
After STZ treatment, the levels of endocrine markers such as
glucagon, insulin and somatostatin were increased [2] while newly
differentiated endocrine cells express insulin, glucagon, and so-
matostatin spontaneously during early pancreas development
[66,67]. The progenitor islet cells of STZ-double transgenic mice co-
express insulin, glucagon and somatostatin in much higher levels
than the untreated double transgenic mice. Therefore diabetic re-
covery in p21 transgenic mice treated with streptozotocin, are
characterized by regeneration in the adult beta islets and this might
be the answer of the possibly activation of early pancreatic devel-
opmental pathways [2].
12. The biological signiﬁcance of p21 associated with diabetic
nephropathy
Renal mesangial cell hypertrophy is a characteristic feature of
diabetic nephropathy which acts as a reaction to renal stress or
injury and is deﬁned by increased protein synthesis. Considering
that p21 controls cell cycle progression and affects DNA replication
while allowing protein synthesis to continue, the implication of p21
in renal mesangial hypertrophy was considered. p21 inhibition by
speciﬁc phosphorothioate antisense oligodeoxynucleotide (ODN)
decreases p21 protein levels in human mesangial cell (MC). It is
known that IGF-1 plays important roles in cellular functions
including cell proliferation related to hypertrophy. In addition,
antisense p21 ODN caused attenuation of IGF-1 (Insulin-like
growth factor 1)-induced p21 levels of MC cells and resulted in
attenuating the hypertrophic effect. These data suggest that
attenuation of p21 may ultimately prove useful in the therapy of
glomerular hypertrophic diseases [68].
13. ER stress-associated apoptosis factor CHOP associated
with type 2 diabetes
CCAAT/enhancer binding protein (C/EBP) homologous protein
(CHOP)/growth arrest and DNA damage 153 is a dominant-negative
member of the C/EBP transcription family. CHOP is a leucine zipper
transcription factor that is present mostly in the cytosol, at low
levels under normal conditions. Induction of CHOP after stress
conditions accumulates in the nucleus [69]. CHOP was identiﬁed as
an ER stress transcription factor that induces apoptosis in response
to ER stress. CHOP expression is strongly induced via IRE1 and PERK
signaling [12,69]. The proapoptotic effect of CHOP that is trans-
duced by Bim [70,71] enhanceswhen ER stress cannot be restrained
by the prosurvival action of the response system, and the levels of
misfolded proteins remain elevated. In this response, CHOP en-
hances a transcription program that promotes the induction of
apoptosis. This includes expression of the proapoptotic Bim and
repression of the anti-apoptotic Bcl-2 (B-cell lymphoma 2). CHOP
also induces death receptor 5 (DR5), which further leads cells to
undergo apoptosis by multiple conditions that cause ER stress [72].
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apoptosis in AKITA mouse
The Akita mouse have a point mutation in the insulin 2 gene
(Ins2) which carry the Cys96Tyr which results in disrupting a di-
sulﬁde bond between A and B chains and causes a drastic confor-
mation change of this molecule. Therefore, mutant insulin is not
secreted and is degraded by the ERAD pathway that is associated
with the induction of ER-stress, which in turn causes b cell
dysfunction and ﬁnally apoptosis [71,73].15. Role of CHOP deletion to the homozygous Ser51Ala
mutant eIF2a
Accumulation of unfolded proteins within the endoplasmic re-
ticulum (ER) decreases mRNA translation via PERK-mediated
phosphorylation of eukaryotic initiation factor 2 on the Ser 51
residue of the a subunit (eIF2a). Diabetes associated with the loss of
PERK activity is speculated to be due to a postnatal loss of b cells
through apoptotic cell death arising from a failure to properly
regulate the endoplasmic reticulum unfolded protein response
(UPR) [74]. PERK deﬁciency may have a crucial role impact on
physiological conditions associated with ER stress [75].
To elucidate the role of eIF2a phosphorylation, homozygous
Ser51Ala mutant eIF2a mice were generated. Mice homozygous for
themutation at the eIF2a phosphorylation site (Ser51Ala) exhibited
a neonatal lethal phenotype associated with accumulation of mis-
folded proteins and defective transport, oxidative stress related to
mitochondrial damage, decreased expression of UPR, anti-oxidantFig. 1. Schematic presentation of mild and intense ER (endoplasmic reticulum) stress, in vi
cellular lipids, glucose deprivation or calcium imbalance, ER homeostasis is disturbed and en
stress UPR sensors are bound to glucose-regulated protein 78 (BiP/GRP78) and remain inactiv
a regulated UPR, mediated by p21 at which high levels of p21 induce cell cycle arrest and inh
ER. During prolonged ER-stress BiP/Grp78 dissociates from these receptors and activates a
endonuclease and results in splicing of the transcription factor XBP-1 (X-box binding prote
proteolysis by site 1 and site 2 proteases. Active PERK phosphorylates the eukaryotic translat
Moreover, phosphorylation of eIF2a induces translation of ATF4 and its target C/EBP-homoand beta cell-associated genes, and ﬁnally with defective gluco-
neogenesis related to severe b-cell deﬁciency. These results indicate
that the UPR has an extensive role than preserving functional ER
protein than originally anticipated and is essential for the in vivo
glucose homeostasis by various mechanisms [76].15.1. Role of CHOP deletion to the heterozygous Ser51Ala mutant
eIF2a
While heterozygous eIF2as/A animals did not spontaneously
manifest b-cell failure, upon feeding themwith a 45% high-fat diet,
these mice developed diabetes characterized by increased fasting
blood glucose, glucose intolerance and a b-cell secretion deﬁciency.
Defective insulin secretion was due to an elevated rate of glucose-
stimulated translation that compromised the activity of the
unfolded protein folding response and led to the distention of the
ER compartment, the prolonged association of misfolded pro-
insulin with the ER chaperone BiP and ﬁnally with the reduced
secretory granule content [3].
These ﬁndings demonstrated that regulation of mRNA trans-
lation phosphorylation of eIF2a is crucial for the maintenance of
functional integrity of endoplasmic reticulum [3]. While eIF2
phosphorylation inhibits protein translation, it is required for the
transcriptional induction of the majority of the ER stress-inducible
genes associated with the UPR, including those encoding for the
glucose-regulated proteins, such as GRP78/BiP, ERp72, GRP94, and
CHOP. CHOP expression is increased in b cells from diabetic mice
and humans. As ER distention and b-cell death in homozygous
Ser51Ala eIF2a islets were apparent, it is evident that there areew of their consequences in b (beta) cell health. Under conditions such as high intra-
doplasmic reticulum activates unfolded protein response (UPR). Normally or under mild
e. Mild stress allows the adaptation, survival and regeneration of the b cells by inducing
ibit apoptosis that facilitates the pro-survival role of the UPR during the initial stages of
cascade of pathways. The release of IRE1 from the BiP, results in the activation of IRE
in-1). Activation of ATF6 into an active transcription factor occurs by intramembrane
ion initiation factor 2 (eIF2a) at Ser 51 leading to the attenuation of protein translation.
logous protein (CHOP) which inhibits p21 transcription and stimulates apoptosis.
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development that is fundamental for b-cell survival [77]. The
requirement of beta cell for eIF2a phosphorylation is not mediated
through Atf4 mRNA because mice lacking ATF4 have no reported
defects in glycemic control [78]. b cells frommicewith homozygous
Ser51Ala eIF2a underwent apoptosis in part signaled through
CHOP. However in CHOP-null mice with heterozygous Ser51Ala
eIF2a mutations b cell mass was increased, b cell function was
improved, and glucose intolerance was prevented compared with
islets from Ser51Ala eIF2a mice with wild type CHOP alleles [3].
These data support the notion that CHOP is involved in apoptosis of
b cells. Nevertheless, CHOP is not the exclusively death signal eli-
cited by ER stress, in the absence of CHOP other apoptotic pathways
are evoked. CHOP deletion prevents b cell apoptosis and improves b
cell function by preventing oxidative damage and preserves ho-
meostasis in ER [3].
In another experiment, eIF2as/s and eIF2as/A mice were fed with
45% HF (high fat) diet for 35e41 weeks. Body mass, glucose toler-
ance and levels of serum insulin were examined. In this model
CHOP deletion increased obesity, and the number of functional b
cells as a consequence of preventing glucose intolerance [3] also
implying the role of CHOP-dependent apoptosis in b cells diabetes.
15.2. Effect of CHOP-null mutation in a HF diet streptozotocin
treated model of T2D
Wild-type and CHOP-null mice were treated with STZ and were
fed with a high cholesterol 60% HF diet for 5e6 weeks. The results
indicated that in wild type mice b cell mass was reduced and ani-
mals developed hyperglycemia. However in CHOP-null mice
improvement of b cell function was observed and glucose homeo-
stasis was maintained. The ﬁndings also indicate that the CHOP-
null mutation in a HF dietefed, STZ-treated non-genetic model of
T2D has an impact to b cell function and recovery [3].
15.3. Effect of CHOP-null mutation in Leprdb/db mice
Leptin deﬁcient mice (db/db) mice are characterized by insulin
resistance, are hypertriglyceridemic, and exhibit impaired glucose
tolerance. Accumulated levels of UPR markers were identiﬁed in
the islets of db/db mice [77,79].
Furthermore, in order to investigate whether CHOP is involved
in the maintenance of functional b cells, heterozygous for leptin
mice and leptin-deﬁcient mice were studied. CHOP deletion in the
leptin-null mice upregulates expression of UPR and anti-oxidative
response markers and decreases expression of proapoptotic
genes. This in turn results in delayed glucose tolerance, elevated b
cell proliferation and prevention of b cell apoptosis [3].
15.4. CHOP deﬁciency protects b cells from oxidative stress related
to ER-stress
Islets from CHOP-deﬁcient or wild type mice were treated with
tunicamycin to block N-linked glycosylation of proteins and to
promote ER-stress. These experiments showed that there was an
increase in the oxidative degradation of proteins and lipids in wild-
type islets [3]. Alternatively, treatment of islets fromwild type and
CHOP/ mice with H2O2, showed the presence of comparable
amounts of oxidative damage in the islets from b-cells from wild
type and CHOP null mice [3]. Consequently, CHOP deletion
decreased the oxidative damage that results from the unfolded
protein response in the ER, but not from general oxidative stress.
These ﬁndings demonstrated that CHOP deletion improves b cell
function and prevents apoptosis by improving the capacity of ER to
produce folded proteins [3].16. Conclusions
The cellular and molecular mechanisms governing ER-stress is
fundamental for understanding the consequences caused by type 2
diabetes. Growing evidence indicates that hyper-activation of the
UPR is indispensable for ER homeostasis and has a role in b cell
failure and dysfunction during diabetes and place the unfolded
protein response as an important mediator in the development of
the disease and the manifestation of its complications. Paradoxi-
cally there are interrelationships between type 2 diabetes and the
balance between survival pathway and apoptosis pathway related
to ER-stress. It is currently believed that over-expression of p21 is
responsible for the recovering of STZ-induced diabetes so it is
implicated in the prosurvival effects of diabetes-related UPR.
Alternatively CHOP deletion determines the transcriptional proﬁle
of the cell to conserve the functional capacity of the ER and
downsize accumulation of ROS, so it engages the apoptotic pathway
(Fig. 1). The potential link between p21 and CHOP regulation imply
novel therapeutic interventions as well as better understanding of
basic aspects of b cell biology.
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